• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21797 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2008     Committee for New Health Technology Assessment (CNHTA) [Procalcitonin (PCT) quantitation]
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Probiotics in the prevention of clostridium difficile-associated colitis and antibiotic associated diarrhea in adult in-patients]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Pro-BNP Peptide in the diagnosis and prognosis of heart failure]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Pro-BNP peptide in the diagnosis and prognosis of heart failure]
2010     Committee for New Health Technology Assessment (CNHTA) [Pro gastrin-releasing peptide test]
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Priorization for patients on waiting lists: development of a generic system]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Priority-setting of patients on waiting list for spine or spinal fusion elective surgery]
2013     National Evidence-based Healthcare Collaborating Agency (NECA) [Priority setting of clinical preventive services for benefits extension]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Priority setting for health technology assessment(HTA) research in Korea]
2011     Andalusian Health Technology Assessment Area (AETSA) [Prioritization of patient decision aids]
2017     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Primary section - surgical techniques and reimbursement]
2003     Norwegian Knowledge Centre for the Health Services (NOKC) [Primary prevention of cardiovascular disease, with emphasis on pharmacological interventions]
2012     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Primary prevention and health promotion in men]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Primary maximal necrosectomy versus a minimally invasive step up approach in patients with necrotising pancreatitis; PANTER, a randomised controlled trial. Dutch Acute Pancreatitis Study Group]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Primary G-CSF prophylaxis during the first two cycles only or throughout all chemotherapy cycles in breast cancer patients at risk of febrile neutropenia]
2018     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Primary care interventions provided to families where children have been subjected to abuse and neglect]
2022     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Primary bariatric endoscopic techniques in adults with or without type 2 diabetes mellitus. Efficacy, effectiveness, and safety]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Price and cost development of orphan drugs]
2009     Committee for New Health Technology Assessment (CNHTA) [PRF1, UNC13D, STX11 gene, mutation[Sequencing]]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Preventive outpatient treatment in affective disorders. Results from a health technology assessment]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Preventive health screenings and health consultations in primary care]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Preventive effects of integrated multidisciplinary care ("ketenzorg") on disabled persons within homes for the elderly, a naturalistic controlled clinical trial]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Prevention of Type 2 Diabetes Mellitus in Primary Health Care through healthy lifestyles: care and recommended clinical interventions]
2013     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Prevention of nephropathy by iodinated contrast media during a radiological intervention]
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of infection after knee arthroplasty]
2013     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of fetal alcohol syndrome]
2012     Norwegian Knowledge Centre for the Health Services (NOKC) [Prevention of allergy among children]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of alcohol misuse among children, youths and young adults]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of alcohol misuse among children, youths and young adults]
2009     Health Council of the Netherlands Gezondheidsraad (GR) [Prevention in the elderly: Focus on functioning in daily life]
2007     The Netherlands Organisation for Health Research and Development (ZonMw) [Preventing preterm birth in women with a previous preterm birth: identification of obstacles to change]
2009     Committee for New Health Technology Assessment (CNHTA) [Pressure wire]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Prescription patterns and safety of benzodiazepines in Korea]
1997     Basque Office for Health Technology Assessment (OSTEBA) [Prescription and management of the hormonal oral contraception (Consensus conference)]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Preoperative virtual planning assisted surgery]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Preoperative risk factors: evidence report for the S3 guideline on treatment of inflammatory diseases of the palatine tonsils/tonsillitis]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Preoperative biliary drainage in patients with obstructive jaundice]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Prenatal screening of down syndrome]
2010     Health Council of the Netherlands Gezondheidsraad (GR) [Prenatal screening for trisomy 13 and 18]
2021     Canary Health Service [Prenatal screening for toxoplasmosis]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Prenatal screening for Down syndrome through fetal DNA sequencing from maternal blood]
2011     Andalusian Health Technology Assessment Area (AETSA) [Prenatal screening for aneuploidy using free fetal DNA in maternal blood. Systematic review of the literature.]
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Prenatal diagnosis]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Prenatal diagnosis: MLPA or karyotyping]
2016     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Prenatal diagnosis through Next Generation Sequencing (NGS)]
2016     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Prenatal diagnosis through Chromosomal Microarray Analysis (CMA)]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Prenatal cell-free DNA in maternal blood screening to assess chromosomal disorders in single pregnancy]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Preimplantational genetic diagnosis (pgt-a) in assisted reproduction technologies]
2005     Basque Office for Health Technology Assessment (OSTEBA) [Preimplantational diagnosis of fragile chromosome X carriers and other hereditary disorders in artificial fertilisation techniques]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Preimplantation genetic screening (PGS) in patients undergoing high-complexity reproduction technologies]
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Preimplantation genetic diagnosis - a health technology assessment]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Pregnancy-induced hypertension and pre-eclampsia after 36 weeks: induction of labour versus expectant monitoring. A comparison of maternal and neonatal outcome, maternal quality of life and costs?]
2009     Health Council of the Netherlands Gezondheidsraad (GR) [Pregnancy immunisation by red blood cells]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Predicting efficient implementation and costs; ultrasound screening for developmental dysplasia of the hip]
2021     Institute for Clinical Effectiveness and Health Policy (IECS) [Precice® motorized intramedullary nail system for limb-length discrepancy]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Precice® intramedullary nail system, with external remote controller, for limb length discrepancy]
2015     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Pre-hospital ECMO for refractory cardiac arrest]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Prasugrel in the treatment of acute coronary syndrome]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pralsetinib (RET fusion-positive NSCLC) - Benefit assessment according to §35a Social Code Book V]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Power Doppler for inflammatory arthropathies]
2019     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Powder bed fusion manufacturing of titanium for customized bone replacements in craneomaxillofacial reconstruction]
1999     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Postoperative use of antiembolism stockings: patient's use, practice and information]
2008     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Postoperative pain treatment at home with an elastomeric pump - a health technology assessment]
2023     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Postoperative antimicrobial prophylaxis for thoracic surgery]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Posterior tibial nerve stimulation in overactive bladder]
2015     The Swedish Council on Health Technology Assessment (SBU) [Post-mortem imaging]
2019     Andalusian Health Technology Assessment Area (AETSA) [Post-introduction observational study of predictive/prognostic tests in breast cancer of the Andalusian Public Health System (SSPA)]
2022     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Post COVID-19 – effective treatment and rehabilitation]
2024     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Post covid and other post infectious diseases]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron-emission tomography for breast cancer]
2001     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Positron emissions tomography (PET) with 18-F-fluorodeoxyglucose (FDG)]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Positron emission tomography: proposal for prioritization of indications]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron emission tomography in combination with computed tomography (PET/CT) in minimal cognitive impairment and dementias]
1999     Basque Office for Health Technology Assessment (OSTEBA) [Positron emission tomography (PET)]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron emission tomography (PET): diagnostic usefulness and indications]
2012     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in recurrent colorectal cancer]
2012     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in ovarian cancer]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in oesophagus cancer]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in malignant melanoma]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in malignant lymphoma]
2010     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in high-grade malignant glioma (grades III and IV)]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in head and neck tumours]
2012     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in bone and soft tissue tumors]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron emission tomography (pet) for routine follow-up of selected neoplasms]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Posaconazole for invasive fungal infection treatment and prevention in neutropenic patients]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Portraits describing pharmacological and non-pharmacological interventions for attention deficit hyperactivity disorder (ADHD) in Quebecers 25 years of age and under]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Portrait of the use of bisphosphonates and denosumab in patients aged 50 years or older with osteoporosis who are covered by the public prescription drug insurance program]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Portrait of coronary revascularization by percutaneous coronary intervention and coronary bypass grafting in Quebec, 2015-2018]
2022     Canary Health Service [Portable neuromodulation stimulation device to improve gait in multiple sclerosis]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Portable home hemodialysis systems]
2023     Norwegian Institute of Public Health (NIPH) [Portable ECG equipment for the diagnosis of atrial fibrillation in the specialist health care: rapid HTA - scoping review]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Porcine biological prosthesis for the management of anal fistula]
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Population ultrasound screening for abdominal aortic aneurysms]
2011     Health Council of the Netherlands Gezondheidsraad (GR) [Population screening for cervical cancer]
2015     Health Council of the Netherlands Gezondheidsraad (GR) [Population Screening Act: prevalence of gastrointestinal tract disorders studied with a video capsule]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ponesimod (multiple sclerosis) - Benefit assessment according to §35a Social Code Book V]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ponesimod (multiple sclerosis) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ponatinib (Philadelphia chromosome positive acute lymphoblastic leukaemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V (expiry of the decision)]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ponatinib (chronic myeloid leukaemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V (expiry of the decision)]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ponatinib - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]